At a glance
HIL Applied Medical is developing a compact, low-cost accelerator for proton therapy, an important innovation in radiation therapy that is much safer than today’s state-of-the-art X-ray capabilities. HIL Applied Medical applies a patented laser-based approach to particle acceleration.
This technological breakthrough, invented by Prof. Arie Zigler from the Hebrew University, enables a dramatic reduction in the size, complexity and cost of a proton accelerator. HIL’s accelerator is expected to become a key enabler of compact, cost-effective proton therapy facilities.
Proton therapy is superior to standard radiation therapy (X-ray) in that it reduces damage to surrounding healthy tissue by over 70%, thereby minimizing side-effects, reducing the occurrence of secondary cancers and improving patient survival and quality of life. Proton therapy is used routinely for treating over 28 types of cancer, and the main obstacle preventing wider-spread use is its prohibitively expensive construction ($150-250 Million) and annual operation (~$10 Million/year) costs. A complete single-room proton therapy system based on HIL’s accelerator is estimated to cost only $8-12 Million – depending on configuration. Currently, there are only 35 proton therapy facilities worldwide, 10 of which are in the US, serving approximately six to eight thousand patients. The US market potential alone is estimated at 300,000 patients, valued at approximately $10 Billion annually.
HIL Applied Medical’s novel laser acceleration technology may have the potential to replace current radiation treatments with a superior clinical and a cost-effective solution system that will be able to capture and serve unmet clinical and market needs.
Proton therapy has been proven to be more effective and safer than conventional forms of radiation therapy.
Integra Holdings, Maayan, OurCrowd.
Extensive business development activity is ongoing to secure the resources required for achieving proof of concept.